NCCN 2017 Congress Webinar Series™: Lung Cancer - Managing Toxicities of Newer Agents

The goal of this educational program is to ensure that members of a multidisciplinary team, including physicians, nurses, pharmacists, and other relevant healthcare professionals, have the knowledge and skills necessary to apply the standards of care to their practices and healthcare settings for

NCCN 2017 Congress Webinar Series™: Lung Cancer - Immunotherapies in Lung Cancer

The goal of this educational program is to ensure that members of a multidisciplinary team, including physicians, nurses, pharmacists, and other relevant healthcare professionals, have the knowledge and skills necessary to apply the standards of care to their practices and healthcare settings for

NCCN 2017 Congress Webinar Series™: Lung Cancer - Sequencing Therapy for Advanced Non-Small Cell Lung Cancer

The goal of this educational program is to ensure that members of a multidisciplinary team, including physicians, nurses, pharmacists, and other relevant healthcare professionals, have the knowledge and skills necessary to apply the standards of care to their practices and healthcare settings for

NCCN 2017 Congress Series™: Lung Cancer

The American Cancer Society (ACS) has estimated that 224,390 new cases of lung cancer will be diagnosed in the United States in 2016 with an estimated 158,080 deaths expected. Lung cancer is the second most commonly diagnosed cancer and is the leading cause of cancer death.

Challenges of Toxicity Management in Immuno-oncology

This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.

NCCN Guidelines® Updates: Non-Small Cell Lung Cancer - Immunotherapies

This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.

NCCN Guidelines® Updates: Non-Small Cell Lung Cancer - Biomarker-based Treatment Selection

This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.

NCCN Guidelines® Updates: Non-Small Cell Lung Cancer - What, When, and How of Biomarker Testing

This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer: Immunotherapy

Join Karen L. Reckamp, MD and Carrie Christiansen, RN, MSN, CFNP from City of Hope Comprehensive Cancer Center as they present their expertise on a range of cases pertaining to lung cancer.

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer: Immunotherapy

Join Karen L. Reckamp, MD and Carrie Christiansen, RN, MSN, CFNP from City of Hope Comprehensive Cancer Center as they present their expertise on a range of cases pertaining to lung cancer.

Pages

Subscribe to RSS - Lung Cancers